Skip to main
CL
CL logo

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 28 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 36%
Sell 4%
Strong Sell 4%

Bulls say

Colgate-Palmolive has demonstrated robust organic sales growth, particularly in China, with an overall organic sales increase of 4.3% driven by a combination of volume growth and pricing adjustments. The company holds a significant share in the global toothpaste market at 41.4% year-to-date and has also increased its share in manual toothbrushes to 32.2%, indicating effective market positioning and share gains. Additionally, the improvement in gross margin, supported by cost-saving initiatives and strategic pricing, enhances the outlook for Colgate-Palmolive as it aims for continued sales growth that aligns with its long-term targets.

Bears say

Colgate-Palmolive reported organic sales growth of 4.3% in 4Q24, falling short of the consensus expectation of approximately 6%, indicating a potential further decline to around 3% in 1H25 and signaling a stagnation in the two-year compound annual growth rate. The company's gross margin in 4Q24 also came in below expectations, with 2025 guidance suggesting that any margin expansion will notably underperform the 240 basis points seen in 2024, thereby limiting the company's capacity for reinvestment amid rising advertising expenditures. Additionally, the pet segment experienced weaker organic sales growth of 2.8%, impacted by lower private label volumes, as overall sales growth decelerated in both emerging and developed markets, contributing to a generally pessimistic outlook for the firm.

Colgate-Palmolive (CL) has been analyzed by 28 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 36% suggest Holding, 4% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 28 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $93.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $93.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.